PTC Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
31.03.25
/
50%
€45.60
Target price
31.03.26
€69.18
Performance (%)
41.45%
Price
12.12.25
€63.00
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc. has seen massive gains of 41.45%. This prediction currently runs until 31.03.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -3.817% | -3.817% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target lowered by analysts at JPMorgan Chase & Co. from $78.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€59.06
07.05.26
07.05.26
78.18%
12.12.25
12.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.40
14.03.25
14.03.25
€71.90
14.03.26
14.03.26
27.53%
12.12.25
12.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€53.50
28.02.25
28.02.25
€69.21
28.02.26
28.02.26
20.56%
12.12.25
12.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.20
19.11.24
19.11.24
€58.53
19.11.25
19.11.25
78.76%
20.11.25
20.11.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.20
20.06.24
20.06.24
€49.47
20.06.25
20.06.25
35.26%
21.06.25
21.06.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€48.82
21.05.25
21.05.25
14.86%
22.05.25
22.05.25